New study tests LASMAR score to improve fibroid surgery planning
NCT ID NCT07578246
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at whether the LASMAR scoring system can predict how well hysteroscopic myomectomy works for women with submucous fibroids. Researchers will check if the score matches surgery time, number of sessions, fluid use, and complications. The goal is to help doctors plan better and reduce risks for patients.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Hysteroscopic myomectomy (surgical procedure)
- What this could lead to
- If successful, this could help doctors better predict surgery time, number of sessions needed, and risks for women with uterine fibroids.
- What could go wrong
- This is a small, early-stage observational study with only 88 participants, so results may not apply to everyone. The LASMAR score may not accurately predict outcomes in all cases.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 88 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jun 2026
An estimate. Start dates often move.
- Expected to finish
-
Jul 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Women undergoing hysteroscopic myomectomy for symptomatic uterine fibroids.
- Ages
-
18 to 45 years
- Sex
-
Female participants only
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Women aged 18-45 years * Type 0,1,2 Fibroids according to Figo classification. * Symptomatic submucous fibroids: Symptoms include abnormal uterine bleeding, pelvic pain or pressure symptoms, infertility or recurrent pregnancy loss. * Fibroids size ≤ 5 cm in diameter * Confirmed diagnosis of leiomyoma by ultrasound . * Hemodynamically Stable Patients: Patients with no significant anemia. Exclusion Criteria: * Contraindications to hysteroscopy (e.g., Pregnancy, pyometra, active infection) * Individuals with significant comorbidities (e.g., severe cardiovascular or respiratory diseases, bleeding diathesis). * Cases requiring concurrent procedures (e.g., Laparoscopic surgeries). * Fibroid Size\>5 cm.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Lazmar scoring , hysteroscopic myomectomy are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.